PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $46,000 | -82.8% | 788 | -77.4% | 0.00% | -77.8% |
Q1 2022 | $267,000 | +154.3% | 3,494 | +99.9% | 0.01% | +125.0% |
Q4 2021 | $105,000 | +2000.0% | 1,748 | +1800.0% | 0.00% | – |
Q3 2021 | $5,000 | -98.8% | 92 | -98.6% | 0.00% | -100.0% |
Q2 2021 | $402,000 | +688.2% | 6,622 | +681.8% | 0.01% | +550.0% |
Q4 2020 | $51,000 | -64.1% | 847 | -68.7% | 0.00% | -87.5% |
Q2 2020 | $142,000 | +202.1% | 2,706 | +118.4% | 0.02% | +14.3% |
Q3 2019 | $47,000 | +113.6% | 1,239 | +145.8% | 0.01% | +133.3% |
Q2 2019 | $22,000 | – | 504 | +4481.8% | 0.01% | – |
Q1 2019 | $0 | -100.0% | 11 | -87.8% | 0.00% | -100.0% |
Q2 2018 | $3,000 | -70.0% | 90 | -72.0% | 0.00% | -80.0% |
Q1 2018 | $10,000 | -33.3% | 321 | -0.3% | 0.01% | -54.5% |
Q4 2017 | $15,000 | +275.0% | 322 | +192.7% | 0.01% | +266.7% |
Q3 2017 | $4,000 | +300.0% | 110 | +423.8% | 0.00% | +200.0% |
Q2 2017 | $1,000 | -97.6% | 21 | -97.7% | 0.00% | -98.2% |
Q1 2017 | $42,000 | – | 931 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |